Imidazoles
1
–
1
of
1
results
1
![Medchemexpress LLC 6-bromo-7-[4-[(5-methyl-3-isoxazolyl)methyl]-1-piperazinyl]-2-[4-(4-methyl-1-piperazinyl)phenyl] | 1095382-05-0 | ≥98.0% | 551.48 g·mol⁻¹ | C26H31BrN8O | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00132390-HY-10804-5MG.JPG-250.jpg)
Medchemexpress LLC 6-bromo-7-[4-[(5-methyl-3-isoxazolyl)methyl]-1-piperazinyl]-2-[4-(4-methyl-1-piperazinyl)phenyl] | 1095382-05-0 | ≥98.0% | 551.48 g·mol⁻¹ | C26H31BrN8O | 5 MG
A potent, orally available Aurora kinase inhibitor active against Aurora A, B, and C that displays antiproliferative activity in multiple tumor cell lines. The compound is supplied as a powder for research use and has documented solubility and storage recommendations for both powder and solution forms.
- Potent inhibition of Aurora A, B, and C with IC50s of 15, 25, and 19 nM.
- Orally bioavailable compound showing antiproliferative activity in tumor cell lines.
- Supplied as a powder with high purity (≥98% by HPLC).
- Molecular weight 551.48 g·mol⁻¹ and formula C26H31BrN8O.
- Soluble in DMSO (16.67 mg/mL) and compatible with common vehicle formulations.
- Recommended storage: powder at -20°C (3 years) or 4°C (2 years); in solvent at -80°C (2 years).
